Human leukocyte antigen susceptibility map for SARS-CoV-2.
Identifieur interne : 000583 ( 2020/Analysis ); précédent : 000582; suivant : 000584Human leukocyte antigen susceptibility map for SARS-CoV-2.
Auteurs : Austin Nguyen [États-Unis] ; Julianne K. David [États-Unis] ; Sean K. Maden [États-Unis] ; Mary A. Wood [États-Unis] ; Benjamin R. Weeder [États-Unis] ; Abhinav Nellore [États-Unis] ; Reid F. Thompson [États-Unis]Source :
- Journal of virology [ 1098-5514 ] ; 2020.
Abstract
Genetic variability across the three major histocompatibility complex (MHC) class I genes (human leukocyte antigen [lsqb]HLA[rsqb] A, B, and C) may affect susceptibility to and severity of severe acute respiratory syndrome 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). We execute a comprehensive in silico analysis of viral peptide-MHC class I binding affinity across 145 HLA -A, -B, and -C genotypes for all SARS-CoV-2 peptides. We further explore the potential for cross-protective immunity conferred by prior exposure to four common human coronaviruses. The SARS-CoV-2 proteome is successfully sampled and presented by a diversity of HLA alleles. However, we found that HLA-B*46:01 had the fewest predicted binding peptides for SARS-CoV-2, suggesting individuals with this allele may be particularly vulnerable to COVID-19, as they were previously shown to be for SARS (Lin M, Tseng H-K, Trejaut JA, Lee H-L, Loo J-H, Chu C-C, Chen P-J, Su Y-W, Lim KH, Tsai Z-U, Lin R-Y, Lin R-S, Huang C-H. BMC Med Genet 4:9. 2003.). Conversely, we found that HLA-B*15:03 showed the greatest capacity to present highly conserved SARS-CoV-2 peptides that are shared among common human coronaviruses, suggesting it could enable cross-protective T-cell based immunity. Finally, we report global distributions of HLA types with potential epidemiological ramifications in the setting of the current pandemic.IMPORTANCE Individual genetic variation may help to explain different immune responses to a virus across a population. In particular, understanding how variation in HLA may affect the course of COVID-19 could help identify individuals at higher risk from the disease. HLA typing can be fast and inexpensive. Pairing HLA typing with COVID-19 testing where feasible could improve assessment of viral severity in the population. Following the development of a vaccine against SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.
DOI: 10.1128/JVI.00510-20
PubMed: 32303592
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000044
- to stream PubMed, to step Curation: 000044
- to stream PubMed, to step Checkpoint: 000464
- to stream Ncbi, to step Merge: 003B56
- to stream Ncbi, to step Curation: 003B56
- to stream Ncbi, to step Checkpoint: 003B56
- to stream Main, to step Merge: 000583
- to stream Main, to step Curation: 000583
- to stream Main, to step Exploration: 000583
- to stream 2020, to step Extraction: 000583
Links to Exploration step
pubmed:32303592Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Human leukocyte antigen susceptibility map for SARS-CoV-2.</title>
<author><name sortKey="Nguyen, Austin" sort="Nguyen, Austin" uniqKey="Nguyen A" first="Austin" last="Nguyen">Austin Nguyen</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="David, Julianne K" sort="David, Julianne K" uniqKey="David J" first="Julianne K" last="David">Julianne K. David</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maden, Sean K" sort="Maden, Sean K" uniqKey="Maden S" first="Sean K" last="Maden">Sean K. Maden</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wood, Mary A" sort="Wood, Mary A" uniqKey="Wood M" first="Mary A" last="Wood">Mary A. Wood</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weeder, Benjamin R" sort="Weeder, Benjamin R" uniqKey="Weeder B" first="Benjamin R" last="Weeder">Benjamin R. Weeder</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nellore, Abhinav" sort="Nellore, Abhinav" uniqKey="Nellore A" first="Abhinav" last="Nellore">Abhinav Nellore</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA nellore@ohsu.edu thompsre@ohsu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Thompson, Reid F" sort="Thompson, Reid F" uniqKey="Thompson R" first="Reid F" last="Thompson">Reid F. Thompson</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA nellore@ohsu.edu thompsre@ohsu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32303592</idno>
<idno type="pmid">32303592</idno>
<idno type="doi">10.1128/JVI.00510-20</idno>
<idno type="wicri:Area/PubMed/Corpus">000044</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000044</idno>
<idno type="wicri:Area/PubMed/Curation">000044</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000044</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000464</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000464</idno>
<idno type="wicri:Area/Ncbi/Merge">003B56</idno>
<idno type="wicri:Area/Ncbi/Curation">003B56</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003B56</idno>
<idno type="wicri:Area/Main/Merge">000583</idno>
<idno type="wicri:Area/Main/Curation">000583</idno>
<idno type="wicri:Area/Main/Exploration">000583</idno>
<idno type="wicri:Area/2020/Extraction">000583</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Human leukocyte antigen susceptibility map for SARS-CoV-2.</title>
<author><name sortKey="Nguyen, Austin" sort="Nguyen, Austin" uniqKey="Nguyen A" first="Austin" last="Nguyen">Austin Nguyen</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="David, Julianne K" sort="David, Julianne K" uniqKey="David J" first="Julianne K" last="David">Julianne K. David</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maden, Sean K" sort="Maden, Sean K" uniqKey="Maden S" first="Sean K" last="Maden">Sean K. Maden</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wood, Mary A" sort="Wood, Mary A" uniqKey="Wood M" first="Mary A" last="Wood">Mary A. Wood</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weeder, Benjamin R" sort="Weeder, Benjamin R" uniqKey="Weeder B" first="Benjamin R" last="Weeder">Benjamin R. Weeder</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nellore, Abhinav" sort="Nellore, Abhinav" uniqKey="Nellore A" first="Abhinav" last="Nellore">Abhinav Nellore</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA nellore@ohsu.edu thompsre@ohsu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Thompson, Reid F" sort="Thompson, Reid F" uniqKey="Thompson R" first="Reid F" last="Thompson">Reid F. Thompson</name>
<affiliation wicri:level="2"><nlm:affiliation>Computational Biology Program; Oregon Health & Science University; Portland, OR, 97239; USA nellore@ohsu.edu thompsre@ohsu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Computational Biology Program; Oregon Health & Science University; Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Genetic variability across the three major histocompatibility complex (MHC) class I genes (human leukocyte antigen [lsqb]HLA[rsqb] A, B, and C) may affect susceptibility to and severity of severe acute respiratory syndrome 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). We execute a comprehensive in silico analysis of viral peptide-MHC class I binding affinity across 145 HLA -A, -B, and -C genotypes for all SARS-CoV-2 peptides. We further explore the potential for cross-protective immunity conferred by prior exposure to four common human coronaviruses. The SARS-CoV-2 proteome is successfully sampled and presented by a diversity of HLA alleles. However, we found that HLA-B*46:01 had the fewest predicted binding peptides for SARS-CoV-2, suggesting individuals with this allele may be particularly vulnerable to COVID-19, as they were previously shown to be for SARS (Lin M, Tseng H-K, Trejaut JA, Lee H-L, Loo J-H, Chu C-C, Chen P-J, Su Y-W, Lim KH, Tsai Z-U, Lin R-Y, Lin R-S, Huang C-H. BMC Med Genet 4:9. 2003.). Conversely, we found that HLA-B*15:03 showed the greatest capacity to present highly conserved SARS-CoV-2 peptides that are shared among common human coronaviruses, suggesting it could enable cross-protective T-cell based immunity. Finally, we report global distributions of HLA types with potential epidemiological ramifications in the setting of the current pandemic.<b>IMPORTANCE</b>
Individual genetic variation may help to explain different immune responses to a virus across a population. In particular, understanding how variation in HLA may affect the course of COVID-19 could help identify individuals at higher risk from the disease. HLA typing can be fast and inexpensive. Pairing HLA typing with COVID-19 testing where feasible could improve assessment of viral severity in the population. Following the development of a vaccine against SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Oregon</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Oregon"><name sortKey="Nguyen, Austin" sort="Nguyen, Austin" uniqKey="Nguyen A" first="Austin" last="Nguyen">Austin Nguyen</name>
</region>
<name sortKey="David, Julianne K" sort="David, Julianne K" uniqKey="David J" first="Julianne K" last="David">Julianne K. David</name>
<name sortKey="Maden, Sean K" sort="Maden, Sean K" uniqKey="Maden S" first="Sean K" last="Maden">Sean K. Maden</name>
<name sortKey="Nellore, Abhinav" sort="Nellore, Abhinav" uniqKey="Nellore A" first="Abhinav" last="Nellore">Abhinav Nellore</name>
<name sortKey="Thompson, Reid F" sort="Thompson, Reid F" uniqKey="Thompson R" first="Reid F" last="Thompson">Reid F. Thompson</name>
<name sortKey="Weeder, Benjamin R" sort="Weeder, Benjamin R" uniqKey="Weeder B" first="Benjamin R" last="Weeder">Benjamin R. Weeder</name>
<name sortKey="Wood, Mary A" sort="Wood, Mary A" uniqKey="Wood M" first="Mary A" last="Wood">Mary A. Wood</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000583 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000583 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= 2020 |étape= Analysis |type= RBID |clé= pubmed:32303592 |texte= Human leukocyte antigen susceptibility map for SARS-CoV-2. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32303592" \ | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |